The tumour microenvironment and immune milieu of cholangiocarcinomaLuca Fabris, Mario Strazzabosco, Antonio Solinas et al.|Liver International|2019Cited by 194
CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo†Maria A. González-Carmona, Volker Schmitz, Veronika Lukacs‐Kornek et al.|Hepatology|2008Cited by 67
Improving immunotherapy of hepatocellular carcinoma (<scp>HCC</scp>) using dendritic cells (<scp>DC</scp>) engineered to express <scp>IL</scp>‐12 <i>in vivo</i>Annabelle Vogt, Maria A. González-Carmona, Ingo G.H. Schmidt‐Wolf et al.|Liver International|2013Cited by 30